Abstract:Purpose: Brown adipose tissue (BAT) is highly thermogenic and contributes to non-shivering thermogenesis. Acute mirabegron (MIRA) ingestion, ranging in doses from 50-200 mg, stimulates beta-3-adrenergic receptors in BAT. This increases resting energy expenditure (REE) and elevates supraclavicular skin temperature (Tsc, marker of BAT activation) in thermoneutral environments for up to 4 h. However, it is not known if the thermogenic effects of different MIRA doses are also observed during exposure to a cool environment. We tested the hypotheses that EE and markers of BAT activity during a 6 h cool environmental exposure would be greater following each dose of MIRA (100 mg, 150 mg and 200 mg) versus a placebo (PLA). Methods: 11 healthy adults (age: 22±2 y; BMI: 26±4 kg/m2; 5 women) completed four, double-blind, randomized study visits involving the acute ingestion of 100 mg, 150 mg, and 200 mg of MIRA (Myrbetriq; Astellas Pharma US) or PLA. 30 min following ingestion, subjects rested in a semi-recumbent position for 6 h in a whole-body indirect calorimeter (20°C, 50% RH). REE was calculated for each study visit. O2 consumption (VO2; ml/kg/min), CO2 production (VCO2; ml/kg/min), and respiratory exchange ratio (RER) were averaged over the last 10 min of each 30 min block. BAT activity was estimated using Tsc assessed via infrared thermography every 30 min and expressed relative to sternal skin temperature and as the area under the curve (AUC) for relative Tsc for each study visit. Mean skin temperature (Tsk; 12 sites), and rectal temperature (Tc) were measured every 30 min. Thermal comfort (1=comfortable, 4=very uncomfortable) and sensation (1=cold, 7=hot) were measured every 30 min. Values are reported as mean ± SD. Results: REE during the 6 h intervention was greater following ingestion of 100 mg (494±75 kcal; p < 0.001), 150 mg (481±67 kcal; p = 0.017), and 200 mg (492±69 kcal; p = 0.001) of MIRA vs. PLA (456±67 kcal). However, there were no differences in REE between doses ( p > 0.05 for all comparisons). There was a main effect of drug dose for VO2 ( p = 0.010), which was greater following ingestion of 100 mg (3.88±0.19 ml/kg/min; p = 0.007) and 150 mg (3.82±0.22 ml/kg/min; p = 0.046) of MIRA vs. PLA (3.59±0.11 ml/kg/min). There was a main effect of drug dose for VCO2 ( p = 0.019), which was greater following ingestion of 100 mg of MIRA vs. PLA (3.03±0.10 vs. 2.84±0.05 ml/kg/min; p = 0.004). There were no dose x time interactions or main effects of dose ( p = 0.421) for RER or BAT activity indexed via relative Tsc ( p > 0.237). However, the AUC for Tsc was greater following ingestion of 100 mg (12.54±7.51°C x min; p = 0.011), 150 mg (10.01±6.05°C x min; p = 0.021), and 200 mg (9.17±5.95°C x min; p = 0.028) of MIRA vs. PLA (4.74±3.86°C x min). There was a main effect of drug dose for Tsk ( p = 0.040) but there was no dose x time interaction ( p = 0.608) and there was no main effect of dose ( p = 0.155) for Tc. There was a main effect of dose for thermal sensation ( p = 0.040), which was greater following ingestion of 100 mg (2.9±0.3; p = 0.011) of MIRA vs. PLA (2.4±0.4). There was no dose x time interaction ( p = 0.528) or main effect of dose ( p = 0.080) for thermal comfort. Conclusions: Our data indicate that acute doses of MIRA (100 mg, 150 mg and 200 mg) elicit greater REE and BAT activity vs. PLA during a 6 h of exposure to a cool environment. However, REE and BAT activity was not different between the MIRA doses. This suggests that beta-3 adrenergic receptor activation in BAT appears to be a physiologically effective method to enhance thermogenesis in cool environments. Funded by: Offce of Naval Research N00014-21-1-2276. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Activation of human brown adipose tissue by a β3-adrenergic receptor agonist

Effects of mirabegron on brown adipose tissue and metabolism in humans: A systematic review and meta-analysis

Regulation of Human Adipose Tissue Activation, Gallbladder Size, and Bile Acid Metabolism by a β3-Adrenergic Receptor Agonist

Brown Adipose Tissue Activation in Humans Increases Plasma Levels of Lipid Mediators

The effects of the β1‐adrenergic receptor antagonist bisoprolol administration on mirabegron‐stimulated human brown adipose tissue thermogenesis

The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans

Berberine Hydrochloride Induces Brown Adipogenesis

Activating Brown Adipose Tissue for Weight Loss and Lowering of Blood Glucose Levels: A MicroPET Study Using Obese and Diabetic Model Mice

Enhanced browning of adipose tissue by mirabegron-microspheres

Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans

Beta-3 Adrenergic Receptor Activation Increases Resting Energy Expenditure and Brown Adipose Tissue Activity in a Cool Environment

Bladder Drug Mirabegron Exacerbates Atherosclerosis Through Activation of Brown Fat-Mediated Lipolysis.

Relationship of brown adipose tissue perfusion and function: a study through β2-adrenoreceptor stimulation

The involvement of the adrenergic nervous system in activating human brown adipose tissue and browning

Is activation of human brown adipose tissue a viable target for weight management?

Brown Adipose Tissue and Regulation of Human Body Weight

Weighing in on the role of brown adipose tissue for treatment of obesity

Activation of β3-adrenoceptors increases in vivo free fatty acid uptake and utilization in brown but not white fat depots in high-fat-fed rats

The Thermogenic Effect of Mirabegron Ingestion During Cool Conditions

Interventions associated with brown adipose tissue activation and the impact on energy expenditure and weight loss: A systematic review